Inogen (INGN) Interest Coverage Ratio Growth (5y) (2018 - 2026)
Inogen (INGN) Interest Coverage Ratio Growth (5y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn |
| 10 | Inogen | 175.41 Mn | 65.24 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.80% |
| Sep 30, 2025 | 37.19% |
| Jun 30, 2025 | 45.90% |
| Mar 31, 2025 | -3.93% |
| Dec 31, 2024 | 38.81% |
| Sep 30, 2024 | -18.59% |
| Jun 30, 2024 | -30.43% |
| Mar 31, 2024 | -15.77% |
| Dec 31, 2023 | -19.82% |
| Sep 30, 2023 | -18.04% |
| Jun 30, 2023 | -15.75% |
| Mar 31, 2023 | -42.65% |
| Dec 31, 2022 | -21.10% |
| Sep 30, 2022 | -17.31% |
| Jun 30, 2022 | -15.81% |
| Mar 31, 2022 | -31.70% |
| Dec 31, 2021 | -16.59% |
| Sep 30, 2021 | -50.57% |
| Jun 30, 2021 | -44.23% |
| Mar 31, 2021 | -15.35% |